feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Wipro beats revenue estimates

trending

WBPRB SI answer key

trending

Mumbai weather: Sunny skies ahead

trending

Infosys ADR shares crash

trending

PM Kisan 21st installment

trending

Australia Women beat Bangladesh Women

trending

New Zealand Springboks tour confirmed

trending

Elderly couple hug during flood

trending

Similipal Tiger Reserve reopens

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Business and Economy / Rubicon Research IPO Subscription Begins, Brokerage Firm Recommends 'Subscribe'

Rubicon Research IPO Subscription Begins, Brokerage Firm Recommends 'Subscribe'

9 Oct

•

Summary

  • Rubicon Research is an integrated pharmaceutical company with a strong U.S. presence
  • Focuses on complex generics, specialty formulations, and value-added products
  • Valued at P/E ratio of ~60x based on FY25 EPS of INR 8.2
Rubicon Research IPO Subscription Begins, Brokerage Firm Recommends 'Subscribe'

On October 9, 2025, the subscription period for Rubicon Research's initial public offering (IPO) is set to commence. Rubicon Research is an integrated pharmaceutical product development company with a strong foothold in the U.S. generics and specialty markets.

The company's focus on complex generics, specialty formulations, and value-added products, supported by its in-house R&D and regulatory capabilities, has positioned it as a key player in the industry. With over 65 commercialized products and a deep development pipeline, Rubicon has demonstrated its ability to combine innovation with cost efficiency.

Brokerage firm Arihant Capital has issued a 'subscribe' rating for the IPO, citing Rubicon's recent entry into the specialty branded space through the Validus acquisition, which is expected to enhance the company's growth visibility. Rubicon's data-driven portfolio strategy and integrated supply chain are also seen as key factors that will ensure sustainable profitability and scalability.

At the upper band of INR 485, the issue is valued at a P/E ratio of approximately 60x, based on an annualized profit after tax (PAT) of INR 8.2 per share in the fiscal year 2025. The IPO comprises an offer for sale (OFS) of INR 8,775 million (18.09 million shares) and a fresh issue of INR 5,000 million (10.31 million shares).

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Rubicon Research focuses on complex generics, specialty formulations, and value-added pharmaceutical products, supported by its robust in-house R&D and regulatory capabilities.
Rubicon Research has over 65 commercialized products in its portfolio.
At the upper band of INR 485, Rubicon Research's IPO is valued at a P/E ratio of approximately 60x, based on an annualized profit after tax (PAT) of INR 8.2 per share in the fiscal year 2025.

Read more news on

Business and Economyside-arrow

Advertisement

Advertisement

Advertisement

You may also like

India's Stock Exchange Fends Off 400 Million Cyberattacks in a Single Day

13 Oct • 14 reads

article image

Indian Stocks Defy Global Volatility, Nifty50 Holds Steady

13 Oct • 18 reads

article image

Figma Shares Surge 15% on ChatGPT Integration Ahead of NYSE Debut

6 Oct • 50 reads

article image

WeWork India's IPO Debut Sees Lukewarm Investor Response

6 Oct • 39 reads

article image

Telecom Firm Pace Digitek Debuts on Exchanges with Modest Premium

6 Oct • 27 reads